KO2.F Korian
- Market cap
- EUR 1.22B
- P/E
- 113.9x
- P/B
- 0.34x
- ROE
- 0.0%
- Dividend yield
- 5.73%
- Fundamental score
- -
Ratios use the latest price and the fiscal year ending Dec 2025.
Is KO2.F undervalued?
Graham numberKO2.F trades 31.0% above its Graham number.
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Korian fundamental analysis
No fundamental analysis for Korian yet.
Korian stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Korian
Clariane SE provides care homes, healthcare facilities and services, and shared living solutions in France, Germany, Benelux, Italy, Spain, and the United Kingdom. It operates long-term care and short stay nursing homes. The company also provides inpatient and outpatient services, full-time hospitalization, day hospitalization, and outpatient care, and operates post-acute and rehabilitation care clinics, mental healthcare clinics, and medicine-surgery-obstetrics facilities. …
Full company profileKorian financial statements
Korian annual financial statements (EUR; K = thousand, M = million, B = billion, T = trillion)
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||||
| Revenue | 2.99B | 3.14B | 3.34B | 3.61B | 3.87B | 4.31B | 4.44B | 5.00B | 5.28B | 5.31B |
| Gross Profit | 2.75B | 2.88B | 3.07B | 3.34B | 3.58B | 4.00B | 4.09B | 4.59B | 4.84B | 4.89B |
| Operating Income | 242M | 287M | 308M | 355M | 286M | 348M | 239M | 317M | 287M | 284M |
| EBITDA | - | 437M | 441M | 786M | 812M | 950M | 909M | 952M | 1.06B | 1.15B |
| Net Income | 131M | 163M | 123M | 115M | 39.4M | 94.6M | 22.1M | -105M | -55.1M | 1.60M |
| EPS | - | 1.86 | 1.39 | 1.28 | 0.38 | 0.90 | 0.21 | -0.99 | -0.15 | 0.00 |
| Balance Sheet | ||||||||||
| Total Assets | 6.49B | 7.11B | 7.62B | 10.9B | 13.2B | 14.3B | 14.6B | 15.2B | 14.3B | 13.8B |
| Total Liabilities | 4.46B | 4.64B | 5.06B | 8.37B | 9.87B | 10.5B | 10.7B | 11.2B | 10.2B | 9.91B |
| Shareholders' Equity | 2.02B | 2.46B | 2.56B | 2.56B | 3.16B | 3.50B | 3.54B | 3.58B | 3.69B | 3.61B |
| Cash & Short-term Investments | 310M | 511M | 550M | 345M | 1.16B | 1.21B | 734M | 678M | 518M | 785M |
| Cash Flow | ||||||||||
| Operating Cash Flow | 307M | 385M | 377M | 766M | 795M | 840M | 862M | 793M | 908M | 1.07B |
| Capital Expenditure | 160M | 189M | 265M | 326M | 520M | 529M | 622M | 484M | 308M | 256M |
| Free Cash Flow | - | 197M | 113M | 426M | 275M | 315M | 240M | 309M | 600M | 816M |
| Ratios | ||||||||||
| ROE | 6.5% | 6.6% | 4.8% | 4.5% | 1.2% | 2.7% | 0.6% | -2.9% | -1.5% | 0.0% |
| ROA | 2.0% | 2.3% | 1.6% | 1.0% | 0.3% | 0.7% | 0.2% | -0.7% | -0.4% | 0.0% |
| Net Profit Margin | 4.4% | 5.2% | 3.7% | 3.2% | 1.0% | 2.2% | 0.5% | -2.1% | -1.0% | 0.0% |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
Korian dividends
- Dividend yield
- 5.73%
- Forward dividend
- -
- Payout ratio
- 4,386.0%
- Ex-dividend date
- Jun 21, 2023
| Fiscal year | Dividends paid | Per share | Payout ratio |
|---|---|---|---|
| 2025 | EUR 70.0M | 0.20 | 4,386.0% |
| 2024 | EUR 50.8M | 0.14 | - |
| 2023 | EUR 65.7M | 0.62 | - |
| 2022 | EUR 57.8M | 0.55 | 262.1% |
| 2021 | EUR 36.4M | 0.35 | 38.5% |
| 2020 | EUR 10.2M | 0.10 | 26.0% |
| 2019 | EUR 24.7M | 0.28 | 21.5% |
| 2018 | EUR 24.9M | 0.28 | 20.2% |
| 2017 | EUR 30.6M | 0.35 | 18.7% |
| 2016 | EUR 28.7M | - | 21.9% |
From the cash flow statement: dividends paid in the fiscal year, divided by that year's shares outstanding. Payout ratio = dividends paid / net income.
Last stock split: 2:1 on Jun 28, 2017.
Who owns Korian
- Insiders 35.81%
- Institutions 36.22%
- Public & others 27.97%
- Shares outstanding 357M
- Free float 136M
Korian company profile
- Company name
- Korian
- Ticker
- KO2.F
- ISIN
- FR0010386334
- Exchange
- Frankfurt Exchange
- Sector
- Healthcare
- Industry
- Health Care Providers & Services
- Employees
- 70,685
- Fiscal year end
- December
- Address
- 21-25, rue Balzac, Paris, France, 75008
- Phone
- 33 1 55 37 52 00
- Website
- clariane.com
About Korian
Clariane SE provides care homes, healthcare facilities and services, and shared living solutions in France, Germany, Benelux, Italy, Spain, and the United Kingdom. It operates long-term care and short stay nursing homes. The company also provides inpatient and outpatient services, full-time hospitalization, day hospitalization, and outpatient care, and operates post-acute and rehabilitation care clinics, mental healthcare clinics, and medicine-surgery-obstetrics facilities. In addition, it offers medicalized nursing homes and alternative living solutions, such as shared houses, assisted living, and domiciliary care, as well as outpatient consultations and diagnostics, and social care services. The company was formerly known as Korian and changed its name to Clariane SE in June 2023. Clariane SE was founded in 2001 and is headquartered in Paris, France.
Korian management
10- Madam Sophie BoissardCEO & Director · born 1970
- Mr. Grégory LovichiGroup Chief Financial Officer · born 1980
- Mr. Christian GhariebCEO of Korian Germany & Member of the Group's Management Board
- Mr. Aymeric MathiasPresident of Clariane France & Member of the Group's Management Board
- Stephane BisseuilHead of Investor Relations
- Mr. Nicolas PecourtGroup Chief Communications Officer
- Ms. Nadege PlouGroup Chief Human Resources Officer · born 1976
- Mr. Rémi BoyerDeputy CEO & Chair of the Sup. Board of Korian Germany and Chair of the BOD of Korian Belgium · born 1967
- Mr. Charles-Antoine PinelGroup Chief Revenue & Development Officer · born 1972
- Mr. Frédéric DurousseauChief Executive Officer of Clariane Real Estate · born 1973